Načítá se...
Size-transformable antigen-presenting cell–mimicking nanovesicles potentiate effective cancer immunotherapy
Artificial antigen-presenting cells (aAPCs) can stimulate CD8(+) T cell activation. While nanosized aAPCs (naAPCs) have a better safety profile than microsized (maAPCs), they generally induce a weaker T cell response. Treatment with aAPCs alone is insufficient due to the lack of autologous antigen-s...
Uloženo v:
| Vydáno v: | Sci Adv |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Association for the Advancement of Science
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7732193/ https://ncbi.nlm.nih.gov/pubmed/33310853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.abd1631 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|